Patents by Inventor Goeran M. Jerstroem

Goeran M. Jerstroem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biometric authentication for, and secure electronic tracking of, restricted over-the-counter drug sales
    Patent number: 11475451
    Abstract: A mobile device is provided that includes biometric sensor(s), and a processor that causes the biometric sensor(s) to acquire a physiological marker of a user, and identify and authenticate the user. The processor sends a message to an authentication server that indicates the user is authenticated, and receives a response from the authentication server that includes a unique authentication code. The processor receives selection of a thereby selected over-the-counter (OTC) drug, and communicates with a point-of-sale (POS) system with contactless payment capability. The processor sends a purchase message to the POS system that includes the unique authentication code, an identifier of the selected OTC drug, and payment information. And the POS system communicates with the authentication server to validate the unique authentication code, and with an authorization server to authorize payment for the selected OTC drug based on the payment information.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: October 18, 2022
    Assignee: Bayer Healthcare LLC
    Inventors: Goeran M. Jerstroem, Michael DeBiasi, Felix Sebastian Kaechele
  • BIOMETRIC AUTHENTICATION FOR, AND SECURE ELECTRONIC TRACKING OF, RESTRICTED OVER-THE-COUNTER DRUG SALES
    Publication number: 20180285880
    Abstract: A mobile device is provided that includes biometric sensor(s), and a processor that causes the biometric sensor(s) to acquire a physiological marker of a user, and identify and authenticate the user. The processor sends a message to an authentication server that indicates the user is authenticated, and receives a response from the authentication server that includes a unique authentication code. The processor receives selection of a thereby selected over-the-counter (OTC) drug, and communicates with a point-of-sale (POS) system with contactless payment capability. The processor sends a purchase message to the POS system that includes the unique authentication code, an identifier of the selected OTC drug, and payment information. And the POS system communicates with the authentication server to validate the unique authentication code, and with an authorization server to authorize payment for the selected OTC drug based on the payment information.
    Type: Application
    Filed: March 27, 2018
    Publication date: October 4, 2018
    Inventors: Goeran M. Jerstroem, Michael DeBiasi, Felix Sebastian Kaechele